Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia—Literature Review

Levodopa remains the primary drug for controlling motor symptoms in Parkinson’s disease through the whole course, but over time, complications develop in the form of dyskinesias, which gradually become more frequent and severe. These abnormal, involuntary, hyperkinetic movements are mainly character...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutny, Michał, Hofman, Jagoda, Klimkowicz-Mrowiec, Aleksandra, Gorzkowska, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509231/
https://www.ncbi.nlm.nih.gov/pubmed/34640395
http://dx.doi.org/10.3390/jcm10194377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509231/
https://www.ncbi.nlm.nih.gov/pubmed/34640395
http://dx.doi.org/10.3390/jcm10194377

Ejemplares similares